Margaret Hoor Han Lo - 18 Mar 2026 Form 3 Insider Report for Regencell Bioscience Holdings Ltd (RGC)

Role
Director
Signature
/s/ James Wai Hong Chung, attorney-in-fact
Issuer symbol
RGC
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 09:16:59 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LO MARGARET HOOR HAN Director C/O 9/F CHINACHEM LEIGHTON PLAZA, 29 LEIGHTON ROAD, CAUSEWAY BAY, HONG KONG, CHINA /s/ James Wai Hong Chung, attorney-in-fact 18 Mar 2026 0002113234

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RGC Ordinary shares, par value $0.00001 604,050 18 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RGC Stock option (right to purchase) 18 Mar 2026 Ordinary shares, par value $0.00001 592,230 $17.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted the option on June 30, 2025 pursuant to the Issuer's 2021 Share Option Plan. The option will vest equally upon each of the four anniversaries of the grant date.

Remarks:

Exhibit 24 - Power of Attorney